Yesterday, Radius Health Inc (NASDAQ:RDUS) shares rose a solid 6% on back of RAD-1901 Phase 1 study clinical data that proved to be better …
Shares of Horizon Pharma PLC (NASDAQ:HZNP) and Radius Health Inc (NASDAQ:RDUS) each plunged more than 10% Thursday following disappointing clinical trial results. Let’s …
Cowen’s healthcare analyst Eric Schmidt weighed in today with a few insights on Radius Health Inc (NASDAQ:RDUS), following a meeting with CEO Bob Ward and members of …
